0 results for 'Goodwin Procter'
Cite as: Cohen v. Viray, 08-3860-cv, NYLJ 1202472745889, at *1 (2d Cir, Decided September 30, 2010)Before: Hall, Livingston, and Chin,* C.JJ.p class="decid
The deal, which comes before the agency that oversees Fannie and Freddie filed any suit against BofA, is the best indicator to date of the potential value of buyback claims against issuers of mortgage-backed securities. The bad news for investors? Analysts say BofA's $2.8 billion payout is a bargain for the bank.
Weil IP star Matt Powers has taken his lumps in recent weeks for his unsuccessful defense of Microsoft in the Texas trial that resulted in a $290 million verdict against the software giant. But he sure came through for Merck. In an opinion that sent the company's shares soaring, a New Jersey judge barred Teva from introducing a generic version of Merck's allergy blockbuster.
Two new California state court suits filed by Grais were the subject of a Sunday New York Times column that noted his strategy of steering clear of hard-to-prove fraud allegations. But there are still a raft of defense firms standing between Grais and a big payday.
Latest Merger Has Midsize D.C. Firms Pondering the Altar
It began, perhaps appropriately enough, at Arabelle, a romantic Manhattan restaurant best known for its role as a Sex and the City set.If the litigation over rights to the superheroes Stan Lee created at Marvel Entertainment were a comic book, Marvel counsel David Fleischer of Paul Hastings would be wearing tights and a cape.
Who's Recusing and Who's Refusing?
The continuing furor over Justice Antonin Scalia's hunting trip with Vice President Dick Cheney has cast a spotlight on the murky world of Supreme Court recusals, where justices decide to recuse -- or not -- without review by their fellow justices or others. A Legal Times survey sheds some light on who steps aside most often, who stays put, and which cases have prompted the judicial do-si-do.The appellate ruling comes too late to keep generic manufacturers of the colon cancer drug Eloxatin out of the market, but the Federal Circuit found that a lower court judge interpreted Sanofi's patent incorrectly when he cleared the way for its rivals.
No Rhyme or Reason to Justices' Recusals
Justice Antonin Scalia's motivation for recusing himself in a case involving the Republic of Croatia may have been revealed in a financial disclosure form he filed: Scalia reported that he had been reimbursed by Croatia for a trip to meet Croatian judges in July 2002.State AI Legislation Is on the Move in 2024
Brought to you by LexisNexis®
Download Now
2024 ESI Risk Management & Litigation Readiness Report
Brought to you by Pagefreezer
Download Now
Creating a Culture of Compliance
Brought to you by Ironclad
Download Now
A Buyer's Guide to Law Firm Software
Brought to you by PracticePanther
Download Now